LOX and gastric cancer: In summary, our results demonstrate that the HIF1A-AS2/RP11-366L20.2-miRNA-29c axis-mediated high expression of LOX results in poor prognosis of gastric cancer by promoting M2 macrophage polarization and tumor immune escape and enhancing drug resistance of cancer cells to chemotherapeutic drugs (Figure 10).